MicroRNA-34 family in cancers: role, mechanism, and therapeutic potential
J Fu, S Imani, MY Wu, RC Wu - Cancers, 2023 - mdpi.com
Simple Summary The dysregulation of the miR-34 family has been shown to play an
important role in tumorigenesis and cancer progression. In this review, we summarized the …
important role in tumorigenesis and cancer progression. In this review, we summarized the …
Prostate cancer and the cell cycle: focusing on the role of microRNAs
Prostate cancer is the most frequent solid tumor in terms of incidence and ranks second only
to lung cancer in terms of cancer mortality among men. It has a considerably high mortality …
to lung cancer in terms of cancer mortality among men. It has a considerably high mortality …
Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises
Prostate cancer (PCa) remains a common cancer with high mortality in men due to its
heterogeneity and the emergence of drug resistance. A critical factor contributing to its …
heterogeneity and the emergence of drug resistance. A critical factor contributing to its …
miRNA/epithelial-mesenchymal axis (EMT) axis as a key player in cancer progression and metastasis: A focus on gastric and bladder cancers
AS Sahib, A Fawzi, RS Zabibah, NA Koka, SA Khudair… - Cellular …, 2023 - Elsevier
The metastasis a major hallmark of tumors that its significant is not only related to the basic
research, but clinical investigations have revealed that majority of cancer deaths are due to …
research, but clinical investigations have revealed that majority of cancer deaths are due to …
[HTML][HTML] Bioinformatics and system biology approaches for identifying potential therapeutic targets for prostate cancer
Prostate cancer (PCa) is the primary cause of cancer-related deaths among men, and its
incidence increases with age. Despite the availability of treatments, the high costs and …
incidence increases with age. Despite the availability of treatments, the high costs and …
The role of microRNAs in hepatocellular cancer: a narrative review focused on tumor microenvironment and drug resistance
A Tavakoli Pirzaman, A Alishah… - … in Cancer Research …, 2024 - journals.sagepub.com
Globally, hepatic cancer ranks fourth in terms of cancer-related mortality and is the sixth
most frequent kind of cancer. Around 80% of liver cancers are hepatocellular carcinomas …
most frequent kind of cancer. Around 80% of liver cancers are hepatocellular carcinomas …
Revolutionizing cancer therapy: nanoformulation of miRNA-34–enhancing delivery and efficacy for various cancer immunotherapies: a review
Despite recent advancements in cancer therapies, challenges such as severe toxic effects,
non-selective targeting, resistance to chemotherapy and radiotherapy, and recurrence of …
non-selective targeting, resistance to chemotherapy and radiotherapy, and recurrence of …
Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent
Use of tumor-suppressive microRNAs (miRNAs) as anti-cancer agents is hindered by the
lack of effective delivery vehicles, entrapment of the miRNA within endocytic compartments …
lack of effective delivery vehicles, entrapment of the miRNA within endocytic compartments …
Drastic Synergy of Lovastatin and Antrodia camphorata Extract Combination against PC3 Androgen-Refractory Prostate Cancer Cells, Accompanied by AXL and …
CJ Yao, CL Chang, MH Hu, CH Liao, GM Lai, TJ Chiou… - Nutrients, 2023 - mdpi.com
Prostate cancer (PC) is the second most frequently diagnosed cancer and the fifth leading
cause of cancer-related death in males worldwide. Early-stage PC patients can benefit from …
cause of cancer-related death in males worldwide. Early-stage PC patients can benefit from …
Developing folate-conjugated miR-34a therapeutic for prostate cancer treatment: Challenges and promises
W Li, Y Wang, X Liu, S Wu, M Wang, SG Turowski… - bioRxiv, 2023 - biorxiv.org
Prostate cancer (PCa) remains a common cancer with high mortality in men due to its
heterogeneity and the emergence of drug resistance. A critical factor contributing to its …
heterogeneity and the emergence of drug resistance. A critical factor contributing to its …